FIRST MANHATTAN CO. LLC. - AVIDITY BIOSCIENCES INC ownership

AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 112 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of AVIDITY BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,276
-42.5%
2000.0%0.00%
Q2 2023$2,218
-27.8%
2000.0%0.00%
Q1 2023$3,070
-30.8%
2000.0%0.00%
Q4 2022$4,438
+47.9%
2000.0%0.00%
Q3 2022$3,000
+50.0%
2000.0%0.00%
Q2 2022$2,000
-33.3%
2000.0%0.00%
Q1 2022$3,000
-25.0%
2000.0%0.00%
Q4 2021$4,0000.0%2000.0%0.00%
Q3 2021$4,0000.0%2000.0%0.00%
Q2 2021$4,0000.0%2000.0%0.00%
Q1 2021$4,0002000.00%
Other shareholders
AVIDITY BIOSCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,571,160$40,096,00020.10%
Aaron Wealth Advisors LLC 524,239$13,378,0004.90%
Octagon Capital Advisors LP 430,041$10,975,0003.80%
EcoR1 Capital, LLC 2,103,950$53,693,0002.89%
RTW INVESTMENTS, LP 3,995,000$101,952,0001.71%
ACUTA CAPITAL PARTNERS, LLC 246,200$6,283,0001.71%
Cormorant Asset Management, LP 2,464,547$62,895,0001.50%
Logos Global Management LP 671,454$17,136,0001.47%
Boxer Capital, LLC 1,121,327$28,616,0000.92%
HighVista Strategies LLC 26,665$680,0000.43%
View complete list of AVIDITY BIOSCIENCES INC shareholders